Skip to main content
SpringerLink
Log in

Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Summary

Somatic cell hybridization between nonmetastatic tumor cells and normal cells of the lymphoreticular system results in hybrid cells manifesting metastatic properties of defined target organ specificity. Thus, fusion of the nonmetastatic BALB/c originated NSI plasmacytoma with C57BL B lymphocytes resulted in hybridomas, each of which were metastatic. Of 10 hybridomas, 7 generated metastases in the spleen and liver, whereas 3 generated liver metastases. The generation of liver metastases by hybridomas which homed to both spleen and liver, but not by those which homed to the liver only, was controlled by the spleen. The acquisition of metastatic properties via somatic cell fusion seems to represent a general principle, in which the normal partner determines the target organ specificity for the metastatic growth. Thus, fusion of SP2/O myeloma cells with syngeneic B lymphocytes also resulted in a hybrid cell metastasizing to the spleen and liver, yet a somatic hybrid between NSI and a macrophage or dendritic-like cell metastasized to the lung. Cell surface molecules encoded by the genome of the normal partner was demonstrated to control the target organ specificity: antibodies against MHC-encoded antigens of the normal B cell partner prevented the generation of metastases by hybridomas metastasizing to the spleen and liver, but not by those metastasizing to the liver only. This is in accordance with the function of MHC molecules on lymphocytes in controlling their homing to lymphoid organs. Hybridomas of T cell lymphomas also manifested metastatic properties. Analysis of the cell surface Thy-1 antigens of a hybridoma (DCH10), produced via somatic fusion between BW5145 lymphoma and a putative macrophage cell indicated that cells of liver metastases (DCH10-Li) generated by the hybrid cells might have undergone further somatic cell fusion in vivo with host (T?) cells. These cells have acquired new metastatic properties, generating metastases in spleen, liver and kidneys. In fact, even the inoculation of the parental BW lymphoma cells resulted in a case of liver metastasis (BW-Li). Such BW-Li cells, upon reinoculation, also generated metastases in the spleen, liver and kidneys. Analysis of the Thyl phenotype indicated that BW-Li cells may also have undergone somatic cell fusion in vivo with host (T?) cells, resulting in the acquisition of metastatic properties. The pattern of cell-cell interactions (adhesion, infiltration) with liver cell monolayers of BW-Li cells and of DCH10-Li (T-cell lymphomas) was identical, and differed from cells of liver metastases of the myeloma-B cell hybridomas which might be based on responses to liver growth signals. Accordingly, the morphology of liver metastases generated by the two categories of hybridomas was different. It appears therefore, that (a) the acquisition of metastatic properties following somatic cell fusion with normal lymphoreticular cells is of a general significance; (b) somatic cell fusion provides an experimental system for the analysis of molecular properties determining the acquisition of metastatic capability; and (c) it may also represent a mechanism for tumor progression in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barski G, Sorieul S, Cornefert F: ‘Hybrid’-type cells in combined cultures of two different mammalian cell strains. J Natl Cancer Inst 26: 1269–1291, 1961.

    Google Scholar 

  2. Barski G, Cornefert F: Characteristics of ‘hybrid’-type cell lines obtained from mixed cultures in vitro. J Natl Cancer Inst 28: 801–821, 1962.

    Google Scholar 

  3. Harris H, Mimmer OJ, Klein G, Worst P, Tachibana T: Suppression of malignancy by cell fusion. Nature 223: 363–368, 1969.

    Google Scholar 

  4. Klein G, Bregula U, Wiener F, Harris H: The analyses of malignancy by cell fusion. I. Hybrids between tumor cells and L cell derivatives. J Cell Sci 8: 659–672, 1971.

    Google Scholar 

  5. Wiener F, Fenyö EM, Klein G: Fusion of tumor cells with host cells. Nature New Biol 238: 155–159, 1972.

    Google Scholar 

  6. Wiener F, Fenyö EM, Klein G: Tumor-host cell hybrids in radiochimeras. Proc Natl Scad Sci USA 71: 147–152, 1974.

    Google Scholar 

  7. Fenyö EM, Wiener F, Klein G, Harris H: Selection of tumor-host cell hybrids from polyoma virus- and methylcholanthrene-induced sarcomas. J Natl Cancer Inst 51: 1865–1875, 1973.

    Google Scholar 

  8. Ber R, Wiener F, Fenyö EM: Proof of in vivo fusion of murine tumor cells with host cells by universal fusers. J Natl Cancer Inst 60: 931–933, 1978.

    Google Scholar 

  9. Lala PK, Santer V, Rahil KS: Spontaneous fusion between Ehrlich ascites tumor cells and host cells in vivo: Kinetics of hybridization, and concurrent changes in the histocompatibility profile of the tumor after propagation in different host strains. Eur J Cancer 16: 487–510, 1979.

    Google Scholar 

  10. Marshall MJ, Shone DG, Windle JM, Worsfold M: Spontaneous fusion of malignant and host mouse cells in culture detected by phosphoglucose isomerase isoenzymes (GPI). Br J Cancer 46: 811–816, 1982.

    Google Scholar 

  11. Goldenberg DM, Pavia RA, Tsao MC: In vivo hybridization of human tumor and normal hamster cells. Nature 250: 649–651, 1974.

    Google Scholar 

  12. Katzav S, De Baetselier P, Tartakovsky B, Segal S, Feldman M: Immunogenetic properties of tumor metastases. In: Vitetta ES (ed) B and T cell Tumors. Academic Press, New York, 1982, pp 233–245.

    Google Scholar 

  13. Katzav S, De Baetselier P, Tartakovsky B, Gorelik E, Segal S, Feldman M: Immunogenetic determinants controlling the metastatic properties of tumor cells. In: Fabris N (ed) Immunoregulation. Plenum Press, New York, 1983, pp 453–463.

    Google Scholar 

  14. De Baetselier P, Katzav S, Gorelik E, Feldman M, Segal S: Differential expression of H-2 gene products in tumor cells is associated with their metastatic properties. Nature 288: 179–181, 1980.

    Google Scholar 

  15. Katzav S, De Baetselier P, Gorelik E, Feldman M, Segal S: Immunologic control of metastasis formation by a methylcholanthrene-induced tumor (T10) in mice: Differential expression of H-2 gene products. Transpl Proc XIII: 742–746, 1981.

    Google Scholar 

  16. De Baetselier P, Gorelik E, Eshhar Z, Ron Y, Katzav S, Feldman M, Segal S: Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B lymphocytes with plasmacytoma cells. J Natl Cancer Inst 67: 1079–1087, 1981.

    Google Scholar 

  17. Witte PL, Ber R: Improved efficiency of hybridoma ascites production by intrasplenic inoculation in mice. J Natl Cancer Inst 70: 575–577, 1983.

    Google Scholar 

  18. Slavin S, Morecki S, Weiss L: The role of the spleen in tumor growth: Kinetics of the murine B cell leukemia (BCL1). J Immunol 124: 586–589, 1980.

    Google Scholar 

  19. Ron Y, De Baetselier P, Segal S: Involvement of the spleen in murine B cell differentiation. Eur J Immunol 11: 94–99, 1981.

    Google Scholar 

  20. Ron Y, De Baetselier P, Feldman M, Segal S: Involvement of the spleen in the control of the immunogenic and phagocytic function of thioglycollate-induced macrophages. Eur J Immunol 11: 608–611, 1981.

    Google Scholar 

  21. De Baetselier P, Gorelik E, Eshhar Z, Ron Y, Katzav S, Feldman M, Segal S: Organ-specific homing of B cell hybridomas. In: Nieuwenhuis P, van den Broek AA, Hanna MG (eds) In vivo immunology. Plenum, New York, 1982, pp 179–185.

    Google Scholar 

  22. Degos L, Pla M, Colombani JM: H-2 restriction for lymphocyte homing into lymph nodes. Eur J Immunol 9: 808–814, 1979.

    Google Scholar 

  23. Woodruff JJ, Gesner BM: The effect of neuraminidase on the fate of transfused lymphocytes. J Exp Med 129: 551–567, 1969.

    Google Scholar 

  24. Schirrmacher V, Cheingsong-Popv R, Arnheiter H: Hepatocyte tumor cell interaction in vitro. I. Conditions for rosette formation and inhibition by anti H-2 antibodies. J Exp Med 151: 984–988, 1980.

    Google Scholar 

  25. Fogel M, Altevogt P, Schirrmacher V: Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation. J Exp Med 157: 371–376, 1983.

    Google Scholar 

  26. Eshhar Z, Mandler R: Changes in tumorigenic and metastatic pattern of thymoma cells induced by their hybridization to normal lymphocytes. In: Vitetta ES (ed) B and T cell tumors. Academic Press, New York, 1982, pp 313–318.

    Google Scholar 

  27. Williams AF, Barclay AN, Letarte-Muirhead M, Morris RJ: Rat Thy-1 antigens from thymus and brain: Their tissue distribution, purification and chemical composition. Cold Spring Harbor Symp Quant Biol 41: 51–61, 1976.

    Google Scholar 

  28. Peters JH: Hybridomas of mouse dendritic cells (DC) expressing phenotypic markers of DC including growth-stimulating action on T-lymphocytes. In: Pusch K, Kirchner H (eds) Mechanisms of lymphocyte activation. Elsevier North Holland, 1981, pp 537–540.

  29. Britz JS, Askenase PW, Ptak W, Steinman RM, Gershon RK: Specialized antigen-presenting cells. Splenic dendritic cells and peritoneal exudate cells induced by mycobacteria activate effector T cells that are resistant to suppresion. J Exp Med 155: 1344–1356, 1982.

    Google Scholar 

  30. Claman HN, Miller SD, Conlov PJ, Moorhedd JW: Control of experimental contact sensitivity. Adv in Immunol 30: 121–158, 1980.

    Google Scholar 

  31. Roos E, van de Pavert I, Middelhoop OP: Infiltration of tumor cells into cultures of isolated hepatocytes. J Cell Sci 47: 385–397, 1981.

    Google Scholar 

  32. Schirrmacher V: Shifts in tumor cell phenotypes induced by signals from the microenvironment. Relevance for the immunobiology of cancer metastasis. Immunobiology 157: 89–98, 1980.

    Google Scholar 

  33. Schirrmacher V, Fogel M, Russmann E, Bosslet K, Altevogt P, Beck L: Antigenic variation in cancer metastasis: Immune escape versus immune control. Cancer Metastasis Rev 1: 241–274, 1982.

    Google Scholar 

  34. Altevogt P, Kurnick JT, Kimura AK, Bosslet K, Schirrmacker V: Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its high metastatic variant. Eur J Immunol 12: 300–307, 1982.

    Google Scholar 

  35. Dennis J, Donaghue TP, Florian M, Kerbel RS: Apparent reversion of stable in vitro genetic markers detected in tumor cells from spontaneous metastases. Nature 292: 242–245, 1981.

    Google Scholar 

  36. Kerbel RS, Dennis JW, Lagarde AE, Frost P: Tumor progression in metastasis: An experimental approach using lectin resistant tumor variants. Cancer Metastasis Rev 1: 93–140, 1982.

    Google Scholar 

  37. Kerbel RS, Lagarde AE, Dennis JW, Donaghue TP: Spontaneous host cell x tumor cell hybridization in vivo: Contribution to the emergence of metastatic cell variants. Mol Cell Biol 3: 523–538, 1983.

    Google Scholar 

  38. Rios A, Laux D, Heppner GH: Patterns of lymphocyte infiltration in tumor sublines of a single mammary adenocarcinoma (Abstract). Proc AACR 28: 1021, 1982.

    Google Scholar 

  39. Roos E, Van de Pavert IV: Antigen-activated T lymphocytes infiltrate hepatocyte cultures in a manner comparable to liver-colonizing lymphosarcoma cells. Clin Exp Metast 1: 173–180, 1983.

    Google Scholar 

  40. Vlodavsky I, Ariav Y, Fuks Z, Altevogt P, Schirrmacher V: Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial basa lamina: Relation to tumor cell metastasis. Cancer Res (in press).

  41. De Baetselier P, Kapon A, Feldman M, Segal S: Activated macrophages modulate the tumorigenicity of 3LL tumor cells. In: Levy E (ed) Advances in pathology, Vol 1. Pergamon Press, Oxford & New York, 1982, pp 305–308.

    Google Scholar 

  42. De Baetselier P, Kapon A, Katzav S, Feldman M, Segal S: Selection of an immunogenic 3LL tumor subline following serial growth in vivo in the local presence of peritoneal macrophages. In: Norman SJ, Sorkin E (eds) Macrophages and natural killer cells. Plenum Publ Corp, New York, 1982, pp 281–288.

    Google Scholar 

  43. Kerbel RS, Florian M, Man MS, Dennis J, McKenzie IFC: Carcinogenicity of tumor cell populations: Origin of a putative H-2 isoantigenic loss variant tumor. J Natl Cancer Inst 64: 1221–1230, 1981.

    Google Scholar 

  44. Frost P, Kerbel RS, Tartamella-Blondo R: Generation of highly metastatic tumors in DBA/2 mice. Invasion Metastasis 1: 22–33, 1981.

    Google Scholar 

  45. Weitzman SA, Stossel TP: Mutation caused by human phagocytes. Science 212: 546–547, 1981.

    Google Scholar 

  46. Weitzman SA, Stossel TP: Effects of oxygen radical scavengers and antioxidants on phagocyte-induced mutagenesis. J Immunol 128: 2770–2772, 1982.

    Google Scholar 

  47. Kripke ML, Gruys E, Fidler IJ: Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent orgin. Cancer Res 38L: 2962–2967, 1978.

    Google Scholar 

  48. Nicolson GL, Winkelhake JL: Organ specificity of bloodborne metastasis determined by cell adhesion. Nature 299: 230, 1975.

    Google Scholar 

  49. Burger MM: The cell surface and metastasis. In: Biology of the cancer cell. Kugler, Amsterdam, 1980, pp 193–208.

    Google Scholar 

  50. Kerbel RS, Dennis JW, Lagarde AE, Frost P: Tumor progression in metastasis. An experimental approach using lectin-resistant tumor variants. Cancer Metastasis Rev 2: 99–140, 1982.

    Google Scholar 

  51. Fidler IJ, Gersten DM, Bodmen MB: Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res. 36: 3160–3169, 1976.

    Google Scholar 

  52. Frost P, Kerbel RS: Immunoselection in vitro of a nonmetastatic variant from a highly metastatic tumor. Int J Cancer 27: 381–385, 1981.

    Google Scholar 

  53. Bosslet K, Schirrmacher V: Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes. J Exp Med 154: 557–562, 1981.

    Google Scholar 

  54. Poste G, Doll J, Fidler IJ: Interactions between clonal subpopulations affect the stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proc Natl Acad Sci USA 78: 6226–6230, 1981.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dienst Algemene Biologie, Instituut voor Moleculaire Biologie, Vrije Universiteit Brussel, Belgium

    P. De Baetselier, L. Brys, L. Remels, M. Gobert & D. Dekegel

  2. Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

    E. Roos

  3. Department of Cell Biology, The Weizmann Institute of Science, Rehovot, Israel

    S. Segal & M. Feldman

Authors
  1. P. De Baetselier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Roos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Brys
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Remels
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Gobert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Dekegel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Segal
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Feldman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Baetselier, P., Roos, E., Brys, L. et al. Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells. Cancer Metast Rev 3, 5–24 (1984). https://doi.org/10.1007/BF00047690

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00047690

Keywords

Search

Navigation